According tomedia reports, the researchers’ earliest estimate is that a successful and viable new vaccine could reach the finish line by the end of this year and be ready to be introduced into the general population. However, judging by the impact of the New Crown pandemic, the change will not happen overnight. Getting everyone vaccinated represents a major logistical challenge. Even so, some scientists worry that the coronavirus vaccine won’t even work, or at least provide little protection to a group of obese people.
According to one estimate, more than 107 million Americans can be classified as “obese.” The researchers say we already know that vaccines that protect against them, from influenza to tetanus and rabies, are less effective for obese people, and that the new vaccine is likely to follow the same pattern.
“Will we have a (COVID-19) vaccine for obese people next year?” No way,” Raz Shaikh, an associate professor of nutrition at the University of North Carolina at Chapel Hill, told CNN. “Does it still work for the obese?” Our forecast is negative. “
The U.S. Centers for Disease Control and Prevention (CDC) has warned that people with a BMI of more than 40, including those thought to be overweight more than 100 pounds, are most likely to become severely ill with the new coronavirus. This designation includes nearly 10 percent of Americans. But as people learn more about the virus, the people it affects and federal officials expand the category of people, including anyone with a body mass index of at least 30, with the number of Americans at greater risk of expanding the number of adults in the United States from coronavirus to more than 42%.
The CDC has pointed out that people with the following conditions are at high risk of being infected with the new coronavirus:
Chronic kidney disease.
COPD (chronic obstructive pulmonary disease)
Obesity (BMI 30 or above)
The immune retardation (weakened immune system) caused by a solid organ transplant.
Severe heart disease, such as heart failure, coronary artery disease, or cardiomyopathy.
Sickle cell disease.
Type 2 diabetes.